Advisor Resource Council Acquires New Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Advisor Resource Council acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 27,337 shares of the company's stock, valued at approximately $2,232,000. Advisor Resource Council owned about 0.06% of Prestige Consumer Healthcare as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare during the 4th quarter worth $27,000. CIBC Private Wealth Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after buying an additional 152 shares during the last quarter. Opal Wealth Advisors LLC acquired a new position in Prestige Consumer Healthcare in the 1st quarter valued at about $38,000. Headlands Technologies LLC purchased a new stake in Prestige Consumer Healthcare during the 4th quarter valued at approximately $40,000. Finally, McIlrath & Eck LLC lifted its position in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after acquiring an additional 154 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH traded up $0.34 on Tuesday, reaching $84.73. 371,482 shares of the company were exchanged, compared to its average volume of 299,242. The company has a 50-day moving average of $83.98 and a 200-day moving average of $82.48. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 19.75, a price-to-earnings-growth ratio of 2.50 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 1-year low of $64.94 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. During the same period in the prior year, the business posted $1.02 earnings per share. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.